The store will not work correctly when cookies are disabled.
16-(1-methyl-5-nitro-1H-imidazol-2-ylthio)hexadecanoic acid
ID: ALA3274669
PubChem CID: 12381540
Max Phase: Preclinical
Molecular Formula: C20H35N3O4S
Molecular Weight: 413.58
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1c([N+](=O)[O-])cnc1SCCCCCCCCCCCCCCCC(=O)O
Standard InChI: InChI=1S/C20H35N3O4S/c1-22-18(23(26)27)17-21-20(22)28-16-14-12-10-8-6-4-2-3-5-7-9-11-13-15-19(24)25/h17H,2-16H2,1H3,(H,24,25)
Standard InChI Key: ZAWNJYXFXCZYAX-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 28 0 0 0 0 0 0 0 0999 V2000
3.0907 -5.8584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4827 -6.5767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2863 -6.4272 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3898 -5.6162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6499 -5.2697 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8804 -6.9925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1105 -5.2233 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.8080 -5.6491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5255 -5.2579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2230 -5.6837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9405 -5.2925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6380 -5.7183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3555 -5.3271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0530 -5.7529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7705 -5.3617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4680 -5.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1854 -5.3963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8830 -5.8221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6004 -5.4309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1330 -7.3187 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5968 -7.9916 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3184 -7.3840 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2979 -5.8567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0154 -5.4655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7129 -5.8913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4304 -5.5001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1279 -5.9259 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4504 -4.6832 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
1 2 2 0
3 4 1 0
4 5 2 0
5 1 1 0
3 6 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
20 21 2 0
20 22 1 0
2 20 1 0
19 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
26 28 2 0
M CHG 2 20 1 22 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 413.58 | Molecular Weight (Monoisotopic): 413.2348 | AlogP: 5.97 | #Rotatable Bonds: 18 |
Polar Surface Area: 98.26 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.95 | CX Basic pKa: 1.06 | CX LogP: 6.65 | CX LogD: 4.24 |
Aromatic Rings: 1 | Heavy Atoms: 28 | QED Weighted: 0.14 | Np Likeness Score: -0.81 |
References
1. Tweit RC, Muir RD, Ziecina S.. (1977) Nitroimidazoles with antibacterial activity against Neisseria gonorrhoeae., 20 (12): [PMID:412966] [10.1021/jm00222a036] |